Clinical Associate Professor
Royal Australasian College of Physicians Internal Medicine/Clinical Haematology, FRACP
Royal College of Pathologists of Australasia Haematopathology, FRCPA
University of Otago, New Zealand Medicine., MBChB
Recent Publications:

•Foltz LM, Dalal BI, Wadsworth LD, Broady R, Chi K, Eisenhauer E, Kobayashi K, Kollmannsburger C. Recognition and management of methemoglobinemia and hemolysis in a G6PD-deficient patient on experimental anticancer drug Triapine. Am J Hematol 81: 210-211, 2006.
•Introna M, Borleri G, Conti E, Franceschetti M, Barbui AM, Broady R*, Dander E, Gaipa G, D’Amica G, Biagi E, Parma M, Pogliani EM, Spinelli O, Baronciani D, Grassi A, Golay J, Barbui T, Biondi A, Rambaldi A. Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study. Haematologica 92: 952-959, 2007. * I developed the protocol for expansion of cytokine-induced killer cells that was used in this clinical study
•Broady R, Yu J, Levings MK. Pro-tolerogenic effects of photodynamic therapy with TH-0942 on Dendritic cells. J Clin Apher 23: 28-91, 2008.
•Chen LY, Chang SD, Sreenivasan GM, Tsang PW, Broady RC, Li CH, Zypchen LN. Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin. Ann Hematol. 2011 Feb;90(2):139-43. Epub 2010 Aug 19.
•Crome SQ, Clive B, Wang AY, Kang CY, Chow V, Yu J, Lai A, Ghahary A, Broady R, Levings MK. Inflammatory effects of ex vivo human Th17 cells are suppressed by regulatory T cells. J Immunol. 2010 Sep 15;185(6):3199-208.
•Broady R, Yu J, Chow V, Tantiworawit A, Kang C, Berg K, Martinka M, Ghoreishi M, Dutz J, Levings MK. Cutaneous GVHD is associated with the expansion of tissue-localized Th1 and not Th17 cells. Blood. 2010 Dec 16;116(25):5748-51.